Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The AMPA glutamate receptor (AMPAR) is an ionotropic glutamate receptor responsible for mediating fast excitatory neurotransmission in the central nervous system. It is a tetrameric complex composed of GluA1-GluA4 subunits. Activation by glutamate or synthetic agonists leads to the opening of a cation channel, primarily permeable to sodium, resulting in neuronal depolarization. Its function is crucial for learning, memory, and synaptic plasticity.
Binding of glutamate or other agonists opens the ion channel, allowing influx of Na+ and, in some cases, Ca2+, leading to neuronal depolarization and excitation.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AMPA glutamate receptor (AMPAR).